{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:55:27Z","timestamp":1793850927548,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-19-PDF-102"],"award-info":[{"award-number":["1-19-PDF-102"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK007052"],"award-info":[{"award-number":["DK007052"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK114012"],"award-info":[{"award-number":["DK114012"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000945","name":"Pittsburgh Foundation","doi-asserted-by":"publisher","award":["MR2020 109502"],"award-info":[{"award-number":["MR2020 109502"]}],"id":[{"id":"10.13039\/100000945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of pathologies that includes steatosis, steatohepatitis (NASH) and fibrosis and is strongly associated with insulin resistance and type 2 diabetes. Changes in mitochondrial function are implicated in the pathogenesis of NAFLD, particularly in the transition from steatosis to NASH. Mitophagy is a mitochondrial quality control mechanism that allows for the selective removal of damaged mitochondria from the cell via the autophagy pathway. While past work demonstrated a negative association between liver fat content and rates of mitophagy, when changes in mitophagy occur during the pathogenesis of NAFLD and whether such changes contribute to the primary endpoints associated with the disease are currently poorly defined. We therefore undertook the studies described here to establish when alterations in mitophagy occur during the pathogenesis of NAFLD, as well as to determine the effects of genetic inhibition of mitophagy via conditional deletion of a key mitophagy regulator, PARKIN, on the development of steatosis, insulin resistance, inflammation and fibrosis. We find that loss of mitophagy occurs early in the pathogenesis of NAFLD and that loss of PARKIN accelerates the onset of key NAFLD disease features. These observations suggest that loss of mitochondrial quality control in response to nutritional stress may contribute to mitochondrial dysfunction and the pathogenesis of NAFLD.<\/jats:p>","DOI":"10.1038\/s41598-023-34710-x","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:36:03Z","timestamp":1683707763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis"],"prefix":"10.1038","volume":"13","author":[{"given":"R.","family":"Undamatla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. G.","family":"Fagunloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. R.","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Pangburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sipula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"St. Croix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Jurczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"34710_CR1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"34710_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Primers 1, 1\u201322 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"34710_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong, R. J. et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148, 547\u2013555 (2015).","journal-title":"Gastroenterology"},{"key":"34710_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg, H., Moschen, A. R. & Roden, M. NAFLD and diabetes mellitus. Nat. Rev. Gastroenterol. Hepatol. 14, 32\u201342 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"34710_CR5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J., George, J., International Consensus Panel. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999\u20132014 (2020).","journal-title":"Gastroenterology"},{"key":"34710_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"34710_CR7","doi-asserted-by":"publisher","first-page":"G400","DOI":"10.1152\/ajpgi.00121.2020","volume":"319","author":"W Dornas","year":"2020","unstructured":"Dornas, W. & Schuppan, D. Mitochondrial oxidative injury: A key player in nonalcoholic fatty liver disease. Am. J. Physiol.-Gastrointestinal. Liver Physiol. 319, G400\u2013G411 (2020).","journal-title":"Am. J. Physiol.-Gastrointestinal. Liver Physiol."},{"key":"34710_CR8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","volume":"282","author":"H Cortez-Pinto","year":"1999","unstructured":"Cortez-Pinto, H. et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA 282, 1659\u20131664 (1999).","journal-title":"JAMA"},{"key":"34710_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/hep.23093","volume":"50","author":"J Szendroedi","year":"2009","unstructured":"Szendroedi, J. et al. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 50, 1079\u20131086 (2009).","journal-title":"Hepatology"},{"key":"34710_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal, A. J. et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183\u20131192 (2001).","journal-title":"Gastroenterology"},{"key":"34710_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S0168-8278(99)80033-6","volume":"31","author":"SH Caldwell","year":"1999","unstructured":"Caldwell, S. H. et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J. Hepatol. 31, 430\u2013434 (1999).","journal-title":"J. Hepatol."},{"key":"34710_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki, C. et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 21, 739\u2013746 (2015).","journal-title":"Cell Metab."},{"key":"34710_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","volume":"20","author":"K Palikaras","year":"2018","unstructured":"Palikaras, K., Lionaki, E. & Tavernarakis, N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat. Cell Biol. 20, 1013\u20131022 (2018).","journal-title":"Nat. Cell Biol."},{"key":"34710_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2015.10.009","volume":"60","author":"N Sun","year":"2015","unstructured":"Sun, N. et al. Measuring in vivo mitophagy. Mol. Cell 60, 685\u2013696 (2015).","journal-title":"Mol. Cell"},{"key":"34710_CR15","doi-asserted-by":"publisher","first-page":"101051","DOI":"10.1016\/j.molmet.2020.101051","volume":"41","author":"LR Edmunds","year":"2020","unstructured":"Edmunds, L. R. et al. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance. Mol. Metab. 41, 101051 (2020).","journal-title":"Mol. Metab."},{"key":"34710_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1101\/gad.262758.115","volume":"29","author":"TM Durcan","year":"2015","unstructured":"Durcan, T. M. & Fon, E. A. The three \u2019P\u2019s of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev. 29, 989\u2013999 (2015).","journal-title":"Genes Dev."},{"key":"34710_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature14879","volume":"524","author":"T Wauer","year":"2015","unstructured":"Wauer, T., Simicek, M., Schubert, A. & Komander, D. Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature 524, 370\u2013374 (2015).","journal-title":"Nature"},{"key":"34710_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.201402104","volume":"205","author":"LA Kane","year":"2014","unstructured":"Kane, L. A. et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143\u2013153 (2014).","journal-title":"J. Cell Biol."},{"key":"34710_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1042\/BJ20140334","volume":"460","author":"A Kazlauskaite","year":"2014","unstructured":"Kazlauskaite, A. et al. Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem. J. 460, 127\u2013139 (2014).","journal-title":"Biochem. J."},{"key":"34710_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.15252\/embr.201540352","volume":"16","author":"A Kazlauskaite","year":"2015","unstructured":"Kazlauskaite, A. et al. Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep. 16, 939\u2013954 (2015).","journal-title":"EMBO Rep."},{"key":"34710_CR21","doi-asserted-by":"publisher","first-page":"120080","DOI":"10.1098\/rsob.120080","volume":"2","author":"C Kondapalli","year":"2012","unstructured":"Kondapalli, C. et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol. 2, 120080 (2012).","journal-title":"Open Biol."},{"key":"34710_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nature13392","volume":"510","author":"F Koyano","year":"2014","unstructured":"Koyano, F. et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510, 162\u2013166 (2014).","journal-title":"Nature"},{"key":"34710_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.molcel.2014.09.007","volume":"56","author":"A Ordureau","year":"2014","unstructured":"Ordureau, A. et al. Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol. Cell 56, 360\u2013375 (2014).","journal-title":"Mol. Cell"},{"key":"34710_CR24","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1073\/pnas.1506593112","volume":"112","author":"A Ordureau","year":"2015","unstructured":"Ordureau, A. et al. Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc. Natl. Acad. Sci. U.S.A. 112, 6637\u20136642 (2015).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"34710_CR25","doi-asserted-by":"publisher","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","volume":"301","author":"M Charlton","year":"2011","unstructured":"Charlton, M. et al. Fast food diet mouse: Novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G825-834 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"34710_CR26","doi-asserted-by":"publisher","first-page":"G666","DOI":"10.1152\/ajpgi.00213.2016","volume":"312","author":"A Krishnan","year":"2017","unstructured":"Krishnan, A. et al. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. Am. J. Physiol. Gastrointest. Liver Physiol. 312, G666\u2013G680 (2017).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"34710_CR27","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1172\/JCI82204","volume":"125","author":"S Satapati","year":"2015","unstructured":"Satapati, S. et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J. Clin. Investig. 125, 4447\u20134462 (2015).","journal-title":"J. Clin. Investig."},{"key":"34710_CR28","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1194\/jlr.M023382","volume":"53","author":"S Satapati","year":"2012","unstructured":"Satapati, S. et al. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 53, 1080\u20131092 (2012).","journal-title":"J. Lipid Res."},{"key":"34710_CR29","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny, N. E., Parks, E. J., Browning, J. D. & Burgess, S. C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14, 804\u2013810 (2011).","journal-title":"Cell Metab."},{"key":"34710_CR30","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/MCB.00167-12","volume":"32","author":"D Glick","year":"2012","unstructured":"Glick, D. et al. BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol. Cell. Biol. 32, 2570\u20132584 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"34710_CR31","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00125-013-2846-8","volume":"56","author":"MK Montgomery","year":"2013","unstructured":"Montgomery, M. K. et al. Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding. Diabetologia 56, 1129\u20131139 (2013).","journal-title":"Diabetologia"},{"key":"34710_CR32","doi-asserted-by":"publisher","first-page":"e13271","DOI":"10.14814\/phy2.13271","volume":"5","author":"M Nascimento-Sales","year":"2017","unstructured":"Nascimento-Sales, M. et al. Is the FVB\/N mouse strain truly resistant to diet-induced obesity?. Physiol. Rep. 5, e13271 (2017).","journal-title":"Physiol. Rep."},{"key":"34710_CR33","doi-asserted-by":"publisher","first-page":"R255","DOI":"10.1152\/ajpregu.00174.2021","volume":"323","author":"JW Strober","year":"2022","unstructured":"Strober, J. W., Fernandez, S., Ye, H. & Brady, M. J. Differential effects of acute versus chronic dietary fructose consumption on metabolic responses in FVB\/N mice. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 323, R255\u2013R266 (2022).","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"34710_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.plipres.2012.08.002","volume":"52","author":"L Hodson","year":"2013","unstructured":"Hodson, L. & Fielding, B. A. Stearoyl-CoA desaturase: Rogue or innocent bystander?. Prog. Lipid Res. 52, 15\u201342 (2013).","journal-title":"Prog. Lipid Res."},{"key":"34710_CR35","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s00125-013-2913-1","volume":"56","author":"N Turner","year":"2013","unstructured":"Turner, N. et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56, 1638\u20131648 (2013).","journal-title":"Diabetologia"},{"key":"34710_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3727\/105221618X15337408678723","volume":"19","author":"AB Rogers","year":"2018","unstructured":"Rogers, A. B. Stress of strains: Inbred mice in liver research. Gene Expr. 19, 61\u201367 (2018).","journal-title":"Gene Expr."},{"key":"34710_CR37","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1053\/gast.2002.37069","volume":"123","author":"S Hillebrandt","year":"2002","unstructured":"Hillebrandt, S., Goos, C., Matern, S. & Lammert, F. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 123, 2041\u20132051 (2002).","journal-title":"Gastroenterology"},{"key":"34710_CR38","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"34710_CR39","doi-asserted-by":"publisher","first-page":"101134","DOI":"10.1016\/j.molmet.2020.101134","volume":"50","author":"M Shum","year":"2021","unstructured":"Shum, M., Ngo, J., Shirihai, O. S. & Liesa, M. Mitochondrial oxidative function in NAFLD: Friend or foe?. Mol. Metab. 50, 101134 (2021).","journal-title":"Mol. Metab."},{"key":"34710_CR40","doi-asserted-by":"publisher","first-page":"e136055","DOI":"10.1172\/JCI136055","volume":"131","author":"R Sharma","year":"2021","unstructured":"Sharma, R. et al. Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity. J. Clin. Invest. 131, e136055 (2021).","journal-title":"J. Clin. Invest."},{"key":"34710_CR41","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2337\/db13-0665","volume":"63","author":"BG Drew","year":"2014","unstructured":"Drew, B. G. et al. HSP72 is a mitochondrial stress sensor critical for parkin action, oxidative metabolism, and insulin sensitivity in skeletal muscle. Diabetes 63, 1488\u20131505 (2014).","journal-title":"Diabetes"},{"key":"34710_CR42","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene, J. C. et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U.S.A. 100, 4078\u20134083 (2003).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"34710_CR43","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino, J. J. et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279, 18614\u201318622 (2004).","journal-title":"J. Biol. Chem."},{"key":"34710_CR44","doi-asserted-by":"publisher","first-page":"G324","DOI":"10.1152\/ajpgi.00108.2015","volume":"309","author":"JA Williams","year":"2015","unstructured":"Williams, J. A., Ni, H.-M., Ding, Y. & Ding, W.-X. Parkin regulates mitophagy and mitochondrial function to protect against alcohol-induced liver injury and steatosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 309, G324-340 (2015).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"34710_CR45","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1074\/jbc.M114.602284","volume":"290","author":"JA Williams","year":"2015","unstructured":"Williams, J. A. et al. Chronic deletion and acute knockdown of parkin have differential responses to acetaminophen-induced mitophagy and liver injury in mice. J. Biol. Chem. 290, 10934\u201310946 (2015).","journal-title":"J. Biol. Chem."},{"key":"34710_CR46","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.27420","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology 61, 486\u2013496 (2015).","journal-title":"Hepatology"},{"key":"34710_CR47","doi-asserted-by":"publisher","first-page":"E298","DOI":"10.1152\/ajpendo.00098.2019","volume":"317","author":"CS McCoin","year":"2019","unstructured":"McCoin, C. S. et al. Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity. Am. J. Physiol. Endocrinol. Metab. 317, E298\u2013E311 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"34710_CR48","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1113\/JP276539","volume":"596","author":"A Von Schulze","year":"2018","unstructured":"Von Schulze, A. et al. Hepatic mitochondrial adaptations to physical activity: Impact of sexual dimorphism, PGC1\u03b1 and BNIP3-mediated mitophagy. J. Physiol. (Lond.) 596, 6157\u20136171 (2018).","journal-title":"J. Physiol. (Lond.)"},{"key":"34710_CR49","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1152\/japplphysiol.00035.2020","volume":"128","author":"KNZ Fuller","year":"2020","unstructured":"Fuller, K. N. Z. et al. Sex and BNIP3 genotype, rather than acute lipid injection, modulate hepatic mitochondrial function and steatosis risk in mice. J. Appl. Physiol. 128, 1251\u20131261 (2020).","journal-title":"J. Appl. Physiol."},{"key":"34710_CR50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","volume":"11","author":"L Yang","year":"2010","unstructured":"Yang, L., Li, P., Fu, S., Calay, E. S. & Hotamisligil, G. S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11, 467\u2013478 (2010).","journal-title":"Cell Metab."},{"key":"34710_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1073\/pnas.1422590112","volume":"112","author":"C L\u00f3pez-Vicario","year":"2015","unstructured":"L\u00f3pez-Vicario, C. et al. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides. Proc. Natl. Acad. Sci. 112, 536\u2013541 (2015).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"34710_CR52","doi-asserted-by":"publisher","first-page":"102570","DOI":"10.1016\/j.redox.2022.102570","volume":"59","author":"P Liu","year":"2022","unstructured":"Liu, P. et al. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease. Redox Biol. 59, 102570 (2022).","journal-title":"Redox Biol."},{"key":"34710_CR53","first-page":"e32866","volume":"7","author":"G-L McLelland","year":"2018","unstructured":"McLelland, G.-L. et al. Mfn2 ubiquitination by PINK1\/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy. Life 7, e32866 (2018).","journal-title":"Life"},{"key":"34710_CR54","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/15548627.2016.1277309","volume":"13","author":"V Gelmetti","year":"2017","unstructured":"Gelmetti, V. et al. PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation. Autophagy 13, 654\u2013669 (2017).","journal-title":"Autophagy"},{"key":"34710_CR55","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/nm.3735","volume":"20","author":"AP Arruda","year":"2014","unstructured":"Arruda, A. P. et al. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med. 20, 1427\u20131435 (2014).","journal-title":"Nat. Med."},{"key":"34710_CR56","doi-asserted-by":"publisher","first-page":"8348","DOI":"10.3390\/ijms23158348","volume":"23","author":"C Jin","year":"2022","unstructured":"Jin, C. et al. Endoplasmic reticulum and mitochondria contacts correlate with the presence and severity of NASH in humans. Int. J. Mol. Sci. 23, 8348 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"34710_CR57","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.redox.2014.06.004","volume":"2","author":"JJ Lemasters","year":"2014","unstructured":"Lemasters, J. J. Variants of mitochondrial autophagy: Types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol. 2, 749\u2013754 (2014).","journal-title":"Redox Biol."},{"key":"34710_CR58","doi-asserted-by":"publisher","first-page":"27879","DOI":"10.1074\/jbc.M110.119537","volume":"285","author":"W-X Ding","year":"2010","unstructured":"Ding, W.-X. et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J. Biol. Chem. 285, 27879\u201327890 (2010).","journal-title":"J. Biol. Chem."},{"key":"34710_CR59","doi-asserted-by":"publisher","first-page":"19094","DOI":"10.1074\/jbc.M111.322933","volume":"287","author":"RA Hanna","year":"2012","unstructured":"Hanna, R. A. et al. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem. 287, 19094\u201319104 (2012).","journal-title":"J. Biol. Chem."},{"key":"34710_CR60","doi-asserted-by":"publisher","first-page":"19500","DOI":"10.1073\/pnas.0708818104","volume":"104","author":"RL Schweers","year":"2007","unstructured":"Schweers, R. L. et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc. Natl. Acad. Sci. U.S.A. 104, 19500\u201319505 (2007).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"34710_CR61","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra, D., Tanaka, A., Suen, D.-F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795\u2013803 (2008).","journal-title":"J. Cell Biol."},{"key":"34710_CR62","doi-asserted-by":"publisher","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate parkin. PLoS Biol. 8, e1000298 (2010).","journal-title":"PLoS Biol."},{"key":"34710_CR63","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.15252\/embr.201540759","volume":"16","author":"AH Chourasia","year":"2015","unstructured":"Chourasia, A. H. et al. Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. EMBO Rep. 16, 1145\u20131163 (2015).","journal-title":"EMBO Rep."},{"key":"34710_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.04.008","author":"LE Drake","year":"2017","unstructured":"Drake, L. E., Springer, M. Z., Poole, L. P., Kim, C. J. & Macleod, K. F. Expanding perspectives on the significance of mitophagy in cancer. Semin. Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2017.04.008 (2017).","journal-title":"Semin. Cancer Biol."},{"key":"34710_CR65","doi-asserted-by":"publisher","first-page":"eabo2510","DOI":"10.1126\/sciadv.abo2510","volume":"8","author":"DE Berardi","year":"2022","unstructured":"Berardi, D. E. et al. Lipid droplet turnover at the lysosome inhibits growth of hepatocellular carcinoma in a BNIP3-dependent manner. Sci Adv 8, eabo2510 (2022).","journal-title":"Sci Adv"},{"key":"34710_CR66","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.bbamcr.2015.02.022","volume":"1853","author":"PA Ney","year":"2015","unstructured":"Ney, P. A. Mitochondrial autophagy: Origins, significance, and role of BNIP3 and NIX. Biochim. Biophys. Acta 1853, 2775\u20132783 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"34710_CR67","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309\u2013314 (2015).","journal-title":"Nature"},{"key":"34710_CR68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler, S. et al. PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat. Cell Biol. 12, 119\u2013131 (2010).","journal-title":"Nat. Cell Biol."},{"key":"34710_CR69","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.molcel.2018.03.012","volume":"70","author":"A Ordureau","year":"2018","unstructured":"Ordureau, A. et al. Dynamics of PARKIN-dependent mitochondrial ubiquitylation in induced neurons and model systems revealed by digital snapshot proteomics. Mol. Cell 70, 211-227.e8 (2018).","journal-title":"Mol. Cell"},{"key":"34710_CR70","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","volume":"44","author":"MD Hirschey","year":"2011","unstructured":"Hirschey, M. D. et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177\u2013190 (2011).","journal-title":"Mol. Cell"},{"key":"34710_CR71","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1042\/BJ20100791","volume":"433","author":"AA Kendrick","year":"2011","unstructured":"Kendrick, A. A. et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 433, 505\u2013514 (2011).","journal-title":"Biochem. J."},{"key":"34710_CR72","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834\u2013840 (2009).","journal-title":"Science"},{"key":"34710_CR73","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.celrep.2012.07.006","volume":"2","author":"A Lundby","year":"2012","unstructured":"Lundby, A. et al. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep. 2, 419\u2013431 (2012).","journal-title":"Cell Rep."},{"key":"34710_CR74","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399\u2013422 (2016).","journal-title":"Cell Res."},{"key":"34710_CR75","doi-asserted-by":"publisher","first-page":"31908","DOI":"10.1074\/jbc.M000684200","volume":"275","author":"JM Macdonald","year":"2000","unstructured":"Macdonald, J. M., Haas, A. L. & London, R. E. Novel mechanism of surface catalysis of protein adduct formation. NMR studies of the acetylation of ubiquitin. J. Biol. Chem. 275, 31908\u201331913 (2000).","journal-title":"J. Biol. Chem."},{"key":"34710_CR76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.15252\/embr.201439152","volume":"16","author":"F Ohtake","year":"2015","unstructured":"Ohtake, F. et al. Ubiquitin acetylation inhibits polyubiquitin chain elongation. EMBO Rep. 16, 192\u2013201 (2015).","journal-title":"EMBO Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34710-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:42:48Z","timestamp":1683708168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34710-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34710"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34710-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2469234\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7575"}}